Friday, Jul 19, 2024 · SEC filings

What the smart money revealed on Jul 19

Real insider buys10insiders · $4.82M
Real insider sales37insiders · $39.1M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

232 insider filings came in. We hid 52 planned (10b5-1) sellers and 121 people whose filings were routine, like grants and tax withholding.

trending_up

Charles Schwab (SCHW) Co-Chairman and CEO Walter Bettinger bought $1.66M

25,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jul 17
$1.66M
trending_up

Innovative Food (IVFH) Director Jefferson Gramm bought $1.33M

1.11M shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jul 17
$1.33M
trending_up

Biohaven (BHVN) Director John Childs bought $1.01M

28,400 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 7 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 7 beat Traded Jul 18
$1.01M
trending_up

Charles Schwab (SCHW) President Richard Wurster bought $620K

10,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jul 17
$620K
trending_down

Morgan Stanley (MS) Executive Chairman James Gorman sold $21M

Not marked as a planned 10b5-1 sale. Sold 57% of the shares they held directly. Still holds 150,000 shares.

Real sale Form 4 Sold 57% of stake Traded Jul 17
$21M
trending_down

Morgan Stanley (MS) Co-President Daniel Simkowitz sold $4.26M

Not marked as a planned 10b5-1 sale. Sold 8% of the shares they held directly. Still holds 442,522 shares.

Real sale Form 4 Traded Jul 17
$4.26M
trending_down

Morgan Stanley (MS) CFO Sharon Yeshaya sold $1.62M

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jul 19
$1.62M
Show 6 more real buys
Show 34 more real sales
ORCL Oracle · Director Leon Panetta · Traded Jul 18
$2.07M
UNH UnitedHealth Group · Chief Accounting Officer Thomas Roos · Traded Jul 17
$1.62M
AZZ AZZ · COO - Metal Coatings Bryan Stovall · Traded Jul 18
$1.23M
PGR Progressive · Director Roger Farah · Traded Jul 18
$1.14M
BNY Bank of New York Mellon · Sr. Exec. Vice President Hanneke Smits · Traded Jul 18
$962K
UNH UnitedHealth Group · EVP and Chief People Officer Erin McSweeney · Traded Jul 18
$869K
MS Morgan Stanley · Deputy CFO Raja Akram · Traded Jul 18
$798K
PGR Progressive · Director Philip Bleser · Traded Jul 17
$466K
BANF Bancfirst · Executive Vice President Dennis Hannah · Traded Jul 19
$320K
CLYM Eliem Therapeutics · EVP Valerie Morisset · Traded Jul 17–18
$289K
IDT IDT · EVP and Corporate Secretary Joyce Mason · Traded Jul 17
$282K
IMVT Immunovant · CEO Peter Salzmann · Traded Jul 17
$258K
PSMT PriceSmart · Director Jeffrey Fisher · Traded Jul 17
$250K
OLLI Ollie's Bargain Outlet · SVP James Comitale · Traded Jul 16
$224K
PSMT PriceSmart · EVP&Chief Transformational Ofc David Price · Traded Jul 19
$176K
CADL Candel Therapeutics · CEO Paul Tak · Traded Jul 17
$146K
SONO Sonos · Principal Accounting Officer Christopher Mason · Traded Jul 17
$144K
MS Morgan Stanley · Director Robert Herz · Traded Jul 17
$107K
CADL Candel Therapeutics · CTO Seshu Tyagarajan · Traded Jul 17
$96.1K
IMVT Immunovant · CFO Eva Barnett · Traded Jul 17
$92.7K
CADL Candel Therapeutics · Chief Scientific Officer Francesca Barone · Traded Jul 17
$90.9K
IMVT Immunovant · Chief Medical Officer William Macias · Traded Jul 17
$90.4K
IMVT Immunovant · Chief Development Officer Julia Butchko · Traded Jul 17
$85.1K
IMVT Immunovant · Chief Legal Officer Mark Levine · Traded Jul 17
$74.4K
CADL Candel Therapeutics · Chief Medical Officer William Nichols · Traded Jul 17
$70.4K
PSMT PriceSmart · Director Edgar Zurcher · Traded Jul 19
$69.7K
CADL Candel Therapeutics · Officer Charles Schoch · Traded Jul 17
$63.9K
SEMR SEMrush · CFO Brian Mulroy · Traded Jul 11
$57.5K
GNTY Guaranty Bancshares · EVP - Guaranty Bank and Trust Robert Sharp · Traded Jul 17
$18.1K
TPET Trio Petroleum · Director John Randall · Traded Jun 18
$9K
GGT Gabelli Multimedia Trust · Director Mario Gabelli · Traded Jul 17
$4.93K
ESPR Esperion Therapeutics · Chief Medical Officer Joanne Foody · Traded Jul 17
$2.38K
ESPR Esperion Therapeutics · Chief Commercial Officer Eric Warren · Traded Jul 17
$280
SLRN Acelyrin · Director Daniel Becker · Traded Jul 17
$7

13F season

Holdings as of Jun 30, 2024 are due Aug 14

54 funds have filed so far. 50 filed for the quarter before.

Biggest real insider buys, Jul 13–19

Open-market buys by officers and directors, filed in the 7 days up to Jul 19.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist